Carnitor^® Injection Is an Effective and Safe Treatment for DCD

Indications and Usage¹

For the prevention and treatment of carnitine deficiency in patients with end stage renal disease who are undergoing dialysis.

Dosing¹

The recommended starting dose is 10–20 mg/kg dry body weight as a slow 2–3 minute bolus injection into the venous return line after each dialysis session. See full Prescribing Information.

Safety¹

Adverse events reported with Carnitor^® use include nausea, vomiting, body odor, gastritis and seizures. There are no reported contraindications or warnings. Only the intravenous form of Carnitor^® is indicated for use in ESRD patients on hemodialysis. See Precautions in Prescribing Information.

NKF Practice Recommendations for the Use of Levocarnitine in DCD²

Clinical manifestations of DCD

• Intradialytic hypotension (IDH)
• Cardiomyopathy
• Anemia hyporesponsive to rHuEPO
• Skeletal muscle weakness

References: 1. Carnitor^® (levocarnitine) Injection package insert. 2. Eknoyan G, et al: Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder: National Kidney Foundation: Carnitine Consensus Conference. Am J Kidney Dis 2003;41:868-876.